Search Results

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) for its PICO Single Use Negative Pressure Wound Therapy System (sNPWT).

The U.K. health assessor the National Institute of Health and Care Excellence (NICE) has issued guidance endorsing the use of Brainomix 360 (formerly known as e-Stroke) to help clinical decision making in stroke.

While approved by the Medicines and Healthcare products Regulatory Agency, the Alzheimer’s drug failed to win the backing of the U.K.’s National Institute for Health and Care Excellence, which said that its benefits were “too small to justify the cost.”

CEL-SCI Corporation announced that the British National Institute for Health and Care Excellence has selected Multikine* to be evaluated as the potential new standard of care for squamous cell carcinoma of the head and neck in the UK.

The U.K.’s National Institute for Health and Care Excellence has endorsed the use of Eli Lilly’s Zepboundfor weight management in patients with BMI of 35 kg/m2 and above and at least one weight-related comorbidity.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that the National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending Evkeeza® (evinacumab) to NHS England.

Rhythm Pharmaceuticals, Inc. announced the National Institute for Health and Care Excellence has issued guidance that recommends IMCIVREE® as an option for treating obesity and the control of hunger in genetically confirmed Bardet-Biedl syndrome in people 6 years of age and over, if they are between 6 and 17 years of age when treatment starts.

PROCEPT BioRobotics® Corporation, a surgical robotics global leader, is pleased to announce that the National Institute for Health and Care Excellence has bestowed its strongest endorsement, the “standard arrangements” recommendation, on Aquablation® therapy for the treatment of benign prostatic hyperplasia.